News

(Reuters) -Shares of U.S. drugmakers rebounded on Monday after an initial selloff as analysts said that President Donald ...
US President Donald Trump signed an executive order requiring drugmakers to lower prices, aligning with international rates.
President Trump signed an executive order aimed at lowering U.S. drug prices to match those of other countries, prompting ...
A U.S. federal judge has sided with a U.S. regulator's decision last year to take Eli Lilly’s blockbuster weight loss and ...
Current health news covers major investments by Merck Animal Health and Gilead Sciences in the U.S., regulatory decisions ...
Global pharmaceutical shares jumped in intraday trading Monday, reversing their pre-market declines, as investors anticipated ...
WASHINGTON - U.S. President Donald Trump signed a wide-reaching executive order on Monday directing drugmakers to lower the ...
US President Donald Trump said Monday he would slash drug prices so they match those abroad, accusing Europe in particular of ...
The president said his executive order will require pharmaceutical companies to price drugs in the U.S. in line with the ...
President Donald Trump will sign an executive order Monday to link the cost of drugs to prices abroad, under a so-called ...
The US leader warns of tariffs if drug prices don’t match other countries within 30 days, targeting 59%-90% cuts.